MedPath

The effect of vitamin D supplementation on reproductive outcomes

Phase 2
Conditions
In vitro fertilization.
Admission for harvesting or implantation of ova
Registration Number
IRCT2015111124999N1
Lead Sponsor
Vice Chancellor for Research of Nursing and Midwifery Faculty, Isfahan University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
85
Inclusion Criteria

Women in the age of 18 to 38 years ; having Primary infertility ; having female infertility approved by gynecologist ; using of long-term down-regulation protocol and then ovulation induction ; not using of vitamin D supplementation before the study ; not having a medical history of systemic disorders such as Cushing's syndrome, hyper or hypothyroidism, hyperprolactimenia ; no liver, kidney and heart diseases ; having BMI Less than or equal to 30 KG/M2 or More than or equal to 18.9 KG/M2 ; not having clinical signs of vitamin D deficiency such as osteomalacia, osteoarthritis, the joint and bone pain and rheumatoid arthritis ; not using of drugs such as Phenytoin, Phenobarbital, Carbamazepine, Isoniazid, Rifampin Theophylline which may affect on vitamin D metabolism ; the absence of congenital or acquired uterine defects ; not having endometriosis.
Exclusion criteria: Using surrogate uterine ; using the Oocyte donation ; Unwillingness to continue cooperation ; not having fertile follicle after injection of gonadotropin hormone.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath